Luchessi, André Ducati; Concheiro, M; Quintela, O; Hirata, Rosario Dominguez Crespo 
; Brion, Marcel; Carracedo, A; Iniguez, A; Lopez-Rivadulla, M; Hirata, Mario Hiroyuki
Fonte: Therapeutic Drug Monitoring. Nome do evento: International Congress of Therapeutic Drug Monitoring and Clinical Toxicology. Unidade: FCF
Assuntos: CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Clopidogrel and acetylsalicylic acid therapy monitoring by liquid chromatography tandem mass spectrometry. Therapeutic Drug Monitoring. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 08 nov. 2024. , 2011APA
Luchessi, A. D., Concheiro, M., Quintela, O., Hirata, R. D. C., Brion, M., Carracedo, A., et al. (2011). Clopidogrel and acetylsalicylic acid therapy monitoring by liquid chromatography tandem mass spectrometry. Therapeutic Drug Monitoring. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Luchessi AD, Concheiro M, Quintela O, Hirata RDC, Brion M, Carracedo A, Iniguez A, Lopez-Rivadulla M, Hirata MH. Clopidogrel and acetylsalicylic acid therapy monitoring by liquid chromatography tandem mass spectrometry. Therapeutic Drug Monitoring. 2011 ;[citado 2024 nov. 08 ]Vancouver
Luchessi AD, Concheiro M, Quintela O, Hirata RDC, Brion M, Carracedo A, Iniguez A, Lopez-Rivadulla M, Hirata MH. Clopidogrel and acetylsalicylic acid therapy monitoring by liquid chromatography tandem mass spectrometry. Therapeutic Drug Monitoring. 2011 ;[citado 2024 nov. 08 ]
